For information on this past event please contact Meetings Management

Thursday 22nd May 2008

SESSION 4:
VACCINE DEVELOPMENTS
Moderator: Greg Glenn (IOMAI Inc., USA)

09.00-09.30
‘LT as antigen and adjuvant using the skin: field efficacy for travellers diarrhea and LT patch adjuvanted injectable pandemic influenza vaccine’
Greg Glenn (IOMAI Inc., Maryland, USA)

09.30-10.00
‘The next generation of vaccines: Increasing potency and decreasing costs via E. coli expression of vaccine antigens targeted to toll-like receptors’
Diane Stark (VaxInnate Corporation, New Haven, Connecticut, USA)

10.00-10.30
‘Pre-clinical evaluation of antigen sparing strategies for H5 influenza vaccines’
Rob Lambkin-Williams (Retroscreen Ltd., London, UK)

10.30-11.00
Coffee Break & Posters

SESSION 4:
Continued
Moderator: Gwyn Davies (SGHMS, UK)

11.00-11.30
‘Stealth Microparticle™: A comprehensive approach to making ‘Triple Threat’ vaccines (multivalent, no cold chain requirements, self-administratable)’
Brandon J. Price, Susan Szathmary and Laszlo Stipkovits (GalenBio Inc., San Diego, California, USA)

11.30-11.50
‘A novel and safe adjuvantation technology for subunit vaccines, using antigen only’
Martijn Gebbink and Barend Bouma (Crossbeta Biosciences BV, Utrecht, The Netherlands)

11.50-12.10
‘Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response’
A.M. Shneider et al. (Cure Lab Inc., Canton, Massachusetts, USA)

12.10-16.15
Lunch & Leisure Time

SESSION 5:
POSTER PRESENTATIONS
Moderator: Jim Brewer (University of Strathclyde, Glasgow, UK)

16.15-17.00
Short presentations from selected poster authors

SESSION 6:
PLENARY SESSION
Moderator: Martin Bachmann (Cytos Biotechnology AG, Switzerland)

17.00-17.30
‘Regulation of isotype switching: Role of toll-like receptors, cytokines and T help’
Martin Bachmann (Cytos Biotechnology AG , Zurich, Switzerland)

17.30-17.50
‘Understanding antigen/adjuvant interactions: A biophysical approach’
LaToya Braun (University of Colorado, Denver, USA)

17.50-18.10
‘Enhancement of the humoral immune response by the complement protein C3d’
Franklin Toapanta Yanchapaxi (Pittsburgh University, USA)

18.10-18.30
‘Balancing adjuvant immunogenicity and reactogenicity’
Nikolai Petrovsky (Flinders University of South Australia, Australia)

Free Evening For Delegates